[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2012173382A3 - Skin composition for external use containing tanshinone ii a as active ingredient - Google Patents

Skin composition for external use containing tanshinone ii a as active ingredient Download PDF

Info

Publication number
WO2012173382A3
WO2012173382A3 PCT/KR2012/004644 KR2012004644W WO2012173382A3 WO 2012173382 A3 WO2012173382 A3 WO 2012173382A3 KR 2012004644 W KR2012004644 W KR 2012004644W WO 2012173382 A3 WO2012173382 A3 WO 2012173382A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
skin
external use
use containing
skin composition
Prior art date
Application number
PCT/KR2012/004644
Other languages
French (fr)
Korean (ko)
Other versions
WO2012173382A2 (en
Inventor
이옥찬
염명훈
조가영
이진영
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Publication of WO2012173382A2 publication Critical patent/WO2012173382A2/en
Publication of WO2012173382A3 publication Critical patent/WO2012173382A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention provides a skin composition for external use containing Tanshinone II A, an isomer thereof, a precursor thereof, a salt thereof, a hydrate thereof, or a solvate thereof as an active ingredient. The composition according to the present invention has the effects of skin whitening, skin moisturizing, and improving skin tone and skin transparency.
PCT/KR2012/004644 2011-06-17 2012-06-13 Skin composition for external use containing tanshinone ii a as active ingredient WO2012173382A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0058902 2011-06-17
KR20110058902A KR101509848B1 (en) 2011-06-17 2011-06-17 Composition for skin external application comprising tanshinone ⅱa as the active ingredient

Publications (2)

Publication Number Publication Date
WO2012173382A2 WO2012173382A2 (en) 2012-12-20
WO2012173382A3 true WO2012173382A3 (en) 2013-03-14

Family

ID=47357592

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/004644 WO2012173382A2 (en) 2011-06-17 2012-06-13 Skin composition for external use containing tanshinone ii a as active ingredient

Country Status (2)

Country Link
KR (1) KR101509848B1 (en)
WO (1) WO2012173382A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420387B (en) * 2016-11-03 2019-08-13 浙江大学 A kind of Chinese medicinal compound targeting lipids nanometer sphere composition and preparation method thereof
KR102611023B1 (en) * 2018-11-21 2023-12-08 (주)아모레퍼시픽 Composition for skin barrier strengthening or moisturizing external skin application containing dehydrogenated abietic acid
CN110787152B (en) * 2019-12-10 2023-11-21 宁夏医科大学 Transdermal gel patch for promoting skin absorption capacity of low medicine and preparation method thereof
JP7395637B2 (en) * 2022-03-28 2023-12-11 株式会社ナリス化粧品 Hyaluronidase inhibitor
CN117487154A (en) * 2023-10-31 2024-02-02 暨南大学 Tanshinone derivative and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100853377B1 (en) * 2006-10-31 2008-08-21 (주)아모레퍼시픽 Anti-aging composition for promoting the proteasome activity of skin cells
WO2009050451A1 (en) * 2007-10-15 2009-04-23 Botanic Century (Beijing) Co. Ltd Antibacterial composition comprising salvia extracts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010106001A (en) 2008-10-31 2010-05-13 Theravalues Corp Ppar activator

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100853377B1 (en) * 2006-10-31 2008-08-21 (주)아모레퍼시픽 Anti-aging composition for promoting the proteasome activity of skin cells
WO2009050451A1 (en) * 2007-10-15 2009-04-23 Botanic Century (Beijing) Co. Ltd Antibacterial composition comprising salvia extracts

Also Published As

Publication number Publication date
WO2012173382A2 (en) 2012-12-20
KR101509848B1 (en) 2015-04-08
KR20120139222A (en) 2012-12-27

Similar Documents

Publication Publication Date Title
MX2015018048A (en) Substituted benzofuranyl and benzoxazolyl compounds and uses thereof.
UA110354C2 (en) Anti-viral compounds
WO2009118107A3 (en) Skin care composition
WO2012068234A3 (en) Antiviral compounds
PH12015501609A1 (en) Phenicol antibacterials
IN2015DN01119A (en)
WO2013061004A8 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
PH12018500377A1 (en) Novel annelated benzamides
EP3354254A4 (en) Skin whitening composition containing beta-mangostin as active ingredient
PH12014501140B1 (en) Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
WO2012173382A3 (en) Skin composition for external use containing tanshinone ii a as active ingredient
WO2015042414A8 (en) Multicyclic compounds and methods of using same
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
UA109460C2 (en) N-hetarylmethyl pyrazolylcarboxamides
WO2012173383A3 (en) Skin composition for external use containing cryptotanshinone as active ingredient
WO2014056851A3 (en) Flavor and fragrance formulation (i)
WO2012116992A3 (en) Oral use of a composition comprising steviol or isosteviol
WO2012065028A3 (en) Substituted tetracyclines
WO2012082942A3 (en) Neuropeptide analogs, compositions, and methods for treating pain
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12800481

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07/04/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12800481

Country of ref document: EP

Kind code of ref document: A2